Advertisement

Topics

Hays Companies Company Profile

00:27 EDT 25th September 2017 | BioPortfolio


News Articles [160 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Cranleigh Scientific: Technical Fragrance Manager – Perfumery – Hays – £40k-£50k

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Cranleigh Scientific: Technical Fragrance Manager – Perfumery – H...

John Hays Joins Merlin International as Director of Federal Healthcare Solutions

VIENNA, Va., June 14, 2017 /PRNewswire/ -- Today Merlin International announced that John Hays would be joining the company as Director of Federal Healthcare Solutions.  Hays brings ov...

Experts: Lack of Remorse Could Bite 'Pharma Bro'

NewsThe 34-year-old defendant faces up to 20 years in prison for his conviction on the most serious counts.Contributed Author: 

'Pharma Bro' Locked Up with Terrorism and Mob Suspects

NewsFederal prison officials wouldn't discuss Shkreli's conditions. All defense attorney Ben Brafman would say of Shkreli's two nights locked up so far is that he 'is doing reasonably well under very ...

Investors: 'Pharma Bro' Shkreli Was Shady—and Profitable

NewsInvestors accused ex-pharmaceutical exec Martin Shkreli of repeatedly giving them the runaround when they tried to pull their money out of his failing health care hedge fund. But the government wi...

Investors: 'Pharma Bro' Shkreli Was Shady and Profitable

NewsInvestors accused ex-pharmaceutical exec Martin Shkreli of repeatedly giving them the runaround when they tried to pull their money out of his failing health care hedge fund. But the government wi...

Prosecutor: Martin Shkreli Repeatedly Lied to Investors

NewsAssistant U.S. Attorney Alixandra Smith said in closing arguments at Shkreli's securities fraud trial that he 'lied to investors to get their money into the funds and then lied to them so they wou...

Investor: 'Pharma Bro' Reported Too-Good-to-Be-True Returns

NewsAn investor who put $300,000 into Martin Shkreli's healthcare industry hedge fund testified Thursday that the former pharmaceutical CEO reported eye-popping returns before abruptly shutting down t...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors

Based on our clinical experience in patients with chronic disease (Hui, Hui, and Johnston, 2006; Hays et al 2005), a review of the literature (Johnston, Xiao and Hui 2007), and inspired by...

Physician Disclosures in the Real World of Conflicting Interests

This study seeks to ascertain the best way to inform patients about their physicians' conflicts of interest (COI) with industry. Currently, there is no institutional or national standard f...

Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma

Asthma is a chronic disease of the lungs characterized by airway inflammation, bronchoconstriction and increased airway responsiveness. Inhaled corticosteroids (ICS), alone or in combinati...

Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD Subjects

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by airflow limitation that is not fully reversible. The mainstay for treatment involves th...

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Pe

This study is a randomized, double-blind, double-dummy, parallel group, multicenter, non-inferiority study. The study will enroll adult and adolescent asthmatic subjects who are currently ...

Companies [580 Associated Companies listed on BioPortfolio]

Hays

Hays is a global leader in specialist recruitment and HR services. We want our customers to recognise the Hays brand and receive a consistent delivery and communication wherever and whenever they do b...

Hays Companies

Richard M. Hays, M.D., P.A.

Richard M. Hays, M.D., P.A., completed his undergraduate education at Johns Hopkins University in Baltimore, his M.D., at the University of Florida College of Medicine in Gainesville, and his residenc...

Delaware North Companies

Delaware North Companies is one of the world's leading hospitality and food service providers. Its family of companies includes Delaware North Companies Parks & Resorts, Delaware North Companies Gamin...

Real Time Companies, LLC

Real Time Companies is the parent holding company of Real Time Consulting, Real Time Optical, and Real Time Analytical, as well as a minority owner of Entellum. All Real Time Comp...

More Information about "Hays Companies" on BioPortfolio

We have published hundreds of Hays Companies news stories on BioPortfolio along with dozens of Hays Companies Clinical Trials and PubMed Articles about Hays Companies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hays Companies Companies in our database. You can also find out about relevant Hays Companies Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record